Unbiased AI-powered news
3 stories related to this topic, newest first.
New York PostUp to 14 million Medicare recipients who are overweight will be eligible for three GLP-1 medications at a $50 copay under a new pilot program. The Medicare GLP-1 Bridge runs from July 2026 through December 2027 and is separate from standard Part D coverage.
Retatrutide, a triple-receptor drug targeting GLP-1, GIP, and glucagon, produced the largest average weight loss reported so far. The medication also carries additional safety considerations.
ecns.cnTeddi Mellencamp discussed on her podcast that she asked doctors for GLP-1 weight loss medication to address steroid-induced weight gain during her Stage 4 cancer battle but was denied. She revealed she was cancer-free in October 2025 after a three-year fight that included multip…